US Stock MarketDetailed Quotes

ACAD ACADIA Pharmaceuticals

Watchlist
  • 15.940
  • +0.260+1.66%
Close Aug 23 16:00 ET
  • 15.940
  • 0.0000.00%
Post 16:35 ET
2.64BMarket Cap83.89P/E (TTM)

ACADIA Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
46.44%241.96M
73.75%205.83M
40.45%726.44M
69.27%231.04M
61.96%211.7M
22.79%165.24M
2.59%118.46M
6.83%517.24M
4.38%136.49M
-0.68%130.71M
Operating revenue
46.44%241.96M
73.75%205.83M
40.45%726.44M
69.27%231.04M
61.96%211.7M
22.79%165.24M
2.59%118.46M
6.83%517.24M
4.38%136.49M
-0.68%130.71M
Cost of revenue
144.40%18.23M
1,276.78%22.95M
309.58%41.64M
641.44%17.89M
584.55%14.62M
179.68%7.46M
-43.49%1.67M
-46.89%10.17M
-5.78%2.41M
-68.03%2.14M
Gross profit
41.80%223.73M
56.58%182.88M
35.05%684.8M
58.98%213.15M
53.27%197.08M
19.62%157.78M
3.80%116.8M
9.05%507.07M
4.59%134.08M
2.92%128.58M
Operating expense
24.92%193.3M
-1.59%167.67M
3.77%758.18M
-1.07%178.21M
59.84%254.85M
-6.53%154.74M
-24.46%170.38M
14.99%730.67M
4.22%180.14M
13.70%159.44M
Selling and administrative expenses
21.98%117.06M
6.67%107.99M
10.15%406.56M
6.77%111.47M
25.33%97.89M
6.75%95.97M
4.71%101.24M
-6.80%369.09M
-1.43%104.4M
-4.36%78.11M
Research and development costs
29.71%76.23M
-13.69%59.68M
-2.75%351.62M
-11.88%66.74M
92.98%156.96M
-22.31%58.77M
-46.34%69.14M
51.02%361.58M
13.14%75.74M
38.88%81.34M
Operating profit
902.21%30.44M
128.39%15.21M
67.18%-73.38M
175.86%34.94M
-87.18%-57.78M
109.02%3.04M
52.59%-53.58M
-31.19%-223.6M
-3.15%-46.06M
-101.73%-30.87M
Net non-operating interest income expense
39.76%6.36M
44.89%5.51M
160.73%17.23M
31.10%4.76M
79.74%4.13M
684.48%4.55M
3,519.05%3.8M
1,018.44%6.61M
2,713.95%3.63M
1,679.07%2.3M
Non-operating interest income
39.76%6.36M
44.89%5.51M
160.73%17.23M
31.10%4.76M
79.74%4.13M
684.48%4.55M
3,519.05%3.8M
1,018.44%6.61M
2,713.95%3.63M
1,679.07%2.3M
Other net income (expense)
131.03%386K
-94.10%286K
44.24%5.11M
0
-30.06%1.51M
-150.30%-1.24M
1,325.00%4.85M
52.08%3.54M
-4.93%1.54M
462.92%2.16M
Other non- operating income (expenses)
131.03%386K
-94.10%286K
44.24%5.11M
--0
-30.06%1.51M
-150.30%-1.24M
1,325.00%4.85M
52.08%3.54M
-4.93%1.54M
462.92%2.16M
Income before tax
486.19%37.18M
146.73%21M
76.09%-51.04M
197.10%39.7M
-97.40%-52.14M
118.90%6.34M
60.08%-44.94M
-27.41%-213.44M
4.70%-40.89M
-78.61%-26.42M
Income tax
-27.46%3.79M
331.86%4.45M
304.98%10.25M
-829.82%-6.09M
1,597.01%13.03M
1,080.36%5.23M
-495.46%-1.92M
621.08%2.53M
341.80%835K
331.33%768K
Net income
2,897.22%33.39M
138.48%16.56M
71.62%-61.29M
209.76%45.8M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
-28.66%-215.98M
3.18%-41.73M
-88.03%-27.18M
Net income continuous Operations
2,897.22%33.39M
138.48%16.56M
71.62%-61.29M
209.76%45.8M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
-28.66%-215.98M
3.18%-41.73M
-88.03%-27.18M
Minority interest income
Net income attributable to the parent company
2,897.22%33.39M
138.48%16.56M
71.62%-61.29M
209.76%45.8M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
-28.66%-215.98M
3.18%-41.73M
-88.03%-27.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
2,897.22%33.39M
138.48%16.56M
71.62%-61.29M
209.76%45.8M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
-28.66%-215.98M
3.18%-41.73M
-88.03%-27.18M
Basic earnings per share
1,900.00%0.2
137.04%0.1
72.39%-0.37
207.69%0.28
-135.29%-0.4
104.76%0.01
61.43%-0.27
-27.62%-1.34
3.70%-0.26
-88.89%-0.17
Diluted earnings per share
1,900.00%0.2
137.04%0.1
72.39%-0.37
207.69%0.28
-135.29%-0.4
104.76%0.01
61.43%-0.27
-27.62%-1.34
3.70%-0.26
-88.89%-0.17
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 46.44%241.96M73.75%205.83M40.45%726.44M69.27%231.04M61.96%211.7M22.79%165.24M2.59%118.46M6.83%517.24M4.38%136.49M-0.68%130.71M
Operating revenue 46.44%241.96M73.75%205.83M40.45%726.44M69.27%231.04M61.96%211.7M22.79%165.24M2.59%118.46M6.83%517.24M4.38%136.49M-0.68%130.71M
Cost of revenue 144.40%18.23M1,276.78%22.95M309.58%41.64M641.44%17.89M584.55%14.62M179.68%7.46M-43.49%1.67M-46.89%10.17M-5.78%2.41M-68.03%2.14M
Gross profit 41.80%223.73M56.58%182.88M35.05%684.8M58.98%213.15M53.27%197.08M19.62%157.78M3.80%116.8M9.05%507.07M4.59%134.08M2.92%128.58M
Operating expense 24.92%193.3M-1.59%167.67M3.77%758.18M-1.07%178.21M59.84%254.85M-6.53%154.74M-24.46%170.38M14.99%730.67M4.22%180.14M13.70%159.44M
Selling and administrative expenses 21.98%117.06M6.67%107.99M10.15%406.56M6.77%111.47M25.33%97.89M6.75%95.97M4.71%101.24M-6.80%369.09M-1.43%104.4M-4.36%78.11M
Research and development costs 29.71%76.23M-13.69%59.68M-2.75%351.62M-11.88%66.74M92.98%156.96M-22.31%58.77M-46.34%69.14M51.02%361.58M13.14%75.74M38.88%81.34M
Operating profit 902.21%30.44M128.39%15.21M67.18%-73.38M175.86%34.94M-87.18%-57.78M109.02%3.04M52.59%-53.58M-31.19%-223.6M-3.15%-46.06M-101.73%-30.87M
Net non-operating interest income expense 39.76%6.36M44.89%5.51M160.73%17.23M31.10%4.76M79.74%4.13M684.48%4.55M3,519.05%3.8M1,018.44%6.61M2,713.95%3.63M1,679.07%2.3M
Non-operating interest income 39.76%6.36M44.89%5.51M160.73%17.23M31.10%4.76M79.74%4.13M684.48%4.55M3,519.05%3.8M1,018.44%6.61M2,713.95%3.63M1,679.07%2.3M
Other net income (expense) 131.03%386K-94.10%286K44.24%5.11M0-30.06%1.51M-150.30%-1.24M1,325.00%4.85M52.08%3.54M-4.93%1.54M462.92%2.16M
Other non- operating income (expenses) 131.03%386K-94.10%286K44.24%5.11M--0-30.06%1.51M-150.30%-1.24M1,325.00%4.85M52.08%3.54M-4.93%1.54M462.92%2.16M
Income before tax 486.19%37.18M146.73%21M76.09%-51.04M197.10%39.7M-97.40%-52.14M118.90%6.34M60.08%-44.94M-27.41%-213.44M4.70%-40.89M-78.61%-26.42M
Income tax -27.46%3.79M331.86%4.45M304.98%10.25M-829.82%-6.09M1,597.01%13.03M1,080.36%5.23M-495.46%-1.92M621.08%2.53M341.80%835K331.33%768K
Net income 2,897.22%33.39M138.48%16.56M71.62%-61.29M209.76%45.8M-139.77%-65.18M103.28%1.11M61.95%-43.02M-28.66%-215.98M3.18%-41.73M-88.03%-27.18M
Net income continuous Operations 2,897.22%33.39M138.48%16.56M71.62%-61.29M209.76%45.8M-139.77%-65.18M103.28%1.11M61.95%-43.02M-28.66%-215.98M3.18%-41.73M-88.03%-27.18M
Minority interest income
Net income attributable to the parent company 2,897.22%33.39M138.48%16.56M71.62%-61.29M209.76%45.8M-139.77%-65.18M103.28%1.11M61.95%-43.02M-28.66%-215.98M3.18%-41.73M-88.03%-27.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 2,897.22%33.39M138.48%16.56M71.62%-61.29M209.76%45.8M-139.77%-65.18M103.28%1.11M61.95%-43.02M-28.66%-215.98M3.18%-41.73M-88.03%-27.18M
Basic earnings per share 1,900.00%0.2137.04%0.172.39%-0.37207.69%0.28-135.29%-0.4104.76%0.0161.43%-0.27-27.62%-1.343.70%-0.26-88.89%-0.17
Diluted earnings per share 1,900.00%0.2137.04%0.172.39%-0.37207.69%0.28-135.29%-0.4104.76%0.0161.43%-0.27-27.62%-1.343.70%-0.26-88.89%-0.17
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg